Status:
COMPLETED
Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)
Lead Sponsor:
Organon and Co
Conditions:
Asthma, Bronchial
Eligibility:
All Genders
6-11 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the effect of montelukast, an approved medication, on the lower leg growth rate in children with mild asthma. The primary hypothesis is that the lower leg len...
Detailed Description
This is a crossover study that consists of a 2-week placebo run-in period, then a first 3-week treatment period, then a 2-week washout period, and then a second 3-week treatment period. Participants w...
Eligibility Criteria
Inclusion
- A 6-month history of asthma with periodic episodes requiring treatment.
Exclusion
- Medical history of a lung disorder (other than asthma) or a recent upper respiratory tract infection.
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2004
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT00092092
Start Date
October 1 2002
End Date
June 1 2004
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.